StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
91
This month
2
This week
1
This year
10
Publishing Date
2023 - 09 - 06
2
2023 - 07 - 03
2
2023 - 05 - 05
1
2023 - 04 - 17
2
2023 - 04 - 12
1
2023 - 03 - 02
2
2023 - 02 - 06
1
2023 - 01 - 31
1
2023 - 01 - 04
1
2022 - 12 - 20
1
2022 - 11 - 23
1
2022 - 11 - 11
1
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 10 - 31
1
2022 - 10 - 06
1
2022 - 08 - 31
1
2022 - 08 - 19
1
2022 - 08 - 11
1
2022 - 08 - 05
2
2022 - 08 - 03
1
2022 - 07 - 18
1
2022 - 07 - 08
1
2022 - 07 - 01
1
2022 - 06 - 07
1
2022 - 06 - 01
1
2022 - 05 - 31
1
2022 - 05 - 27
1
2022 - 05 - 04
1
2022 - 04 - 18
1
2022 - 04 - 13
1
2022 - 04 - 07
1
2022 - 03 - 24
1
2022 - 03 - 02
2
2022 - 03 - 01
1
2022 - 02 - 17
1
2022 - 02 - 04
1
2022 - 01 - 14
1
2022 - 01 - 05
1
2021 - 12 - 21
1
2021 - 12 - 08
1
2021 - 11 - 19
1
2021 - 11 - 03
1
2021 - 11 - 02
1
2021 - 10 - 27
1
2021 - 10 - 13
1
2021 - 10 - 06
1
2021 - 08 - 25
1
2021 - 08 - 23
1
2021 - 08 - 09
1
2021 - 07 - 19
1
2021 - 07 - 15
1
2021 - 06 - 17
1
2021 - 06 - 07
1
2021 - 05 - 20
1
2021 - 05 - 07
1
2021 - 04 - 15
1
2021 - 02 - 26
1
2021 - 02 - 04
1
2021 - 01 - 12
1
Sector
Communications
1
Distribution services
1
Electronic technology
1
Energy minerals
1
Finance
1
Health technology
91
Industrial services
1
Manufacturing
1
N/a
2
Non-energy minerals
1
Process industries
2
Producer manufacturing
1
Technology services
1
Utilities
1
Tags
Agreement
3
Alliances
1
Alymsys
2
Application
5
Approval
15
Australia
1
Authorized
1
Bijuva
1
Bioscience
1
Biosimilar
6
Biotech
1
Business
1
Ceo
1
China
1
Clinical-trials-phase-iii
2
Conference
6
Disease
5
Drug
5
Earnings
14
Esg
1
Events
10
Fda
15
Fda-approvals
6
Financial
6
Financial results
5
First
2
Fylnetra
1
Global
2
Growing
1
Growth
1
Health
1
Hiv
2
Injection
3
Innovation
1
Integration
1
Ipx-203
1
Ipx203
7
J.p. morgan healthcare conference
1
Legal
1
License
2
Lyvispah
1
Market
4
Mergers-and-acquisitions
1
N/a
14
Parkinson
2
Parkinson’s
3
Patent
2
People
4
Pharm-country
26
Pharmaceutical
4
Phase 3
3
Report
14
Research
8
Response
3
Results
29
Rtu
2
Therapeutics
3
Treatment
3
Trial
3
Year
4
Entities
Abbvie inc.
2
Acadia pharmaceuticals inc.
1
Adams resources & energy, inc.
1
Advanced drainage systems, inc.
1
Agnico eagle mines limited
1
Algonquin power & utilities corp.
1
Alkermes plc
2
Alnylam pharmaceuticals, inc.
1
American woodmark corporation
1
Amgen inc.
2
Amneal pharmaceuticals, inc.
91
Amphastar pharmaceuticals, inc.
1
Amphenol corporation
1
Ampio pharmaceuticals, inc.
1
Ani pharmaceuticals, inc.
1
Antero resources corporation
1
Apple inc.
1
Applied materials, inc.
1
Arista networks, inc.
1
Axcella health inc.
1
Baxter international inc.
1
Berry global group, inc.
1
Blueprint medicines corporation
1
Bristol-myers squibb company
1
Broadcom inc.
1
Brookfield renewable partners l.p.
1
Cadence design systems, inc.
1
Canadian natural resources limited
1
Canadian solar inc.
1
Cf industries holdings, inc.
1
Cyclerion therapeutics, inc.
1
Eli lilly and company
5
Endo international plc
2
Epizyme, inc.
1
Exelixis, inc.
1
Forward pharma a/s
1
Galecto, inc.
1
Gilead sciences, inc.
1
Glaxosmithkline plc
3
I-mab
1
Ibio, inc.
1
Idexx laboratories, inc.
1
Ies holdings, inc.
1
Incyte corporation
2
Infinity pharmaceuticals, inc.
1
Ionis pharmaceuticals, inc.
1
Iron mountain incorporated
1
Ironwood pharmaceuticals, inc.
1
Jazz pharmaceuticals plc
1
Johnson & johnson
1
Leap therapeutics, inc.
1
Mallinckrodt plc
1
Mimedx group, inc
1
Mirati therapeutics, inc.
1
Myriad genetics, inc.
1
Neurocrine biosciences, inc.
1
Novartis ag
1
Orange
1
Teva pharmaceutical industries limited
2
Therapeuticsmd, inc.
2
Symbols
A
429
ABBV
1024
ABT
1787
ALPMF
332
ALPMY
332
AMGN
742
AZN
665
AZNCF
448
BAX
483
BDX
796
BGNE
323
BHC
389
BIIB
381
BIO
449
BMY
662
BNTX
366
BSX
575
BWAY
330
DHR
785
FNCTF
489
GILD
500
GLAXF
658
GMAB
297
GOOG
301
GOOGL
302
GSK
884
HEPA
403
HOLX
328
ILMN
451
INCY
444
JNJ
4583
LLY
1709
MDT
1285
MOR
314
MPSYF
270
MRK
337
MRNA
349
MS
620
NKTR
366
NVO
632
NVS
1241
NVSEF
1031
OCX
482
PFE
692
PHG
962
PKI
274
PRVB
348
QGEN
369
REGN
419
RYLPF
440
SNY
4539
SNYNF
3597
STRO
270
SYK
536
TAK
421
TEVJF
631
TMO
1622
TXMD
278
VTRS
364
VXRT
314
Exchanges
Amex
3
Nasdaq
14
Nyse
91
Crawled Date
2023 - 09 - 06
2
2023 - 07 - 06
2
2023 - 07 - 03
2
2023 - 04 - 17
2
2023 - 04 - 12
1
2023 - 03 - 02
2
2023 - 02 - 06
1
2023 - 01 - 31
1
2023 - 01 - 04
1
2022 - 12 - 20
1
2022 - 11 - 23
1
2022 - 11 - 11
1
2022 - 11 - 04
1
2022 - 11 - 02
1
2022 - 11 - 01
1
2022 - 10 - 06
1
2022 - 08 - 31
1
2022 - 08 - 19
1
2022 - 08 - 11
1
2022 - 08 - 05
2
2022 - 08 - 03
1
2022 - 07 - 18
1
2022 - 07 - 08
1
2022 - 07 - 01
1
2022 - 06 - 07
1
2022 - 06 - 01
1
2022 - 05 - 31
1
2022 - 05 - 27
1
2022 - 05 - 04
1
2022 - 04 - 18
1
2022 - 04 - 13
1
2022 - 04 - 07
1
2022 - 03 - 24
1
2022 - 03 - 02
2
2022 - 03 - 01
1
2022 - 02 - 17
1
2022 - 02 - 04
1
2022 - 01 - 14
1
2022 - 01 - 05
1
2021 - 12 - 21
1
2021 - 12 - 08
1
2021 - 11 - 19
1
2021 - 11 - 03
1
2021 - 11 - 02
1
2021 - 10 - 27
1
2021 - 10 - 13
1
2021 - 10 - 06
1
2021 - 08 - 25
1
2021 - 08 - 23
1
2021 - 08 - 09
1
2021 - 07 - 19
1
2021 - 07 - 15
1
2021 - 06 - 17
1
2021 - 06 - 07
1
2021 - 05 - 20
1
2021 - 05 - 07
1
2021 - 04 - 15
1
2021 - 02 - 26
1
2021 - 02 - 04
1
2021 - 01 - 12
1
Crawled Time
00:00
2
09:00
1
11:00
11
12:00
6
12:15
1
12:20
1
12:30
4
13:00
15
13:15
1
13:20
2
13:30
3
14:00
16
14:15
1
14:20
1
14:30
1
15:30
1
16:00
1
17:00
1
18:00
3
19:00
3
20:00
1
21:00
6
22:00
7
23:00
2
Source
investor.alkermes.com
2
www.biospace.com
77
www.globenewswire.com
3
www.prnewswire.com
9
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
sector :
Health technology
symbols :
AMRX
save search
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
Published:
2024-04-16
(Crawled : 14:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
-3.25%
|
O:
-1.08%
H:
1.09%
C:
-0.55%
rtu
first
Amneal to Report First Quarter 2024 Results on May 3, 2024
Published:
2024-04-10
(Crawled : 13:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
-6.46%
|
O:
-0.52%
H:
3.86%
C:
0.0%
first
report
results
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
Published:
2024-03-25
(Crawled : 23:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
-11.7%
|
O:
0.0%
H:
0.33%
C:
-2.64%
fda
approval
Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203
Published:
2024-02-27
(Crawled : 14:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
-7.9%
|
O:
-1.89%
H:
1.75%
C:
0.0%
ipx203
biotech
agreement
Amneal to Participate at Upcoming Investor Conference
Published:
2024-02-13
(Crawled : 13:30)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
-8.38%
|
O:
-3.84%
H:
2.57%
C:
-0.45%
conference
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
Published:
2024-02-08
(Crawled : 21:00)
- globenewswire.com
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
-1.83%
|
O:
0.18%
H:
1.83%
C:
1.83%
ipx203
drug
resubmission
application
response
I-Mab Signs Agreement to Divest its Assets and Business Operations in China
Published:
2024-02-07
(Crawled : 11:00)
- prnewswire.com
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
-4.29%
|
O:
0.0%
H:
0.0%
C:
-4.29%
IMAB
|
$1.805
0.28%
280K
|
Health Technology
|
-10.45%
|
O:
2.49%
H:
0.97%
C:
-2.91%
business
agreement
china
Deb Autor, Former FDA Deputy Commissioner, Appointed CEO of Healthcare Innovation Catalysts
Published:
2024-02-01
(Crawled : 13:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
0.19%
|
O:
2.8%
H:
0.55%
C:
0.18%
fda
ceo
innovation
Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203
Published:
2024-01-25
(Crawled : 12:30)
- globenewswire.com
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
-1.29%
|
O:
1.57%
H:
0.73%
C:
-0.82%
ipx203
license
pharmaceuticals
therapeutics
agreement
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
Published:
2024-01-10
(Crawled : 14:30)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
-5.8%
|
O:
0.0%
H:
0.7%
C:
-3.16%
Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
Published:
2023-12-21
(Crawled : 16:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
1.32%
|
O:
1.13%
H:
3.83%
C:
3.55%
conference
Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results and Raises Full Year 2023 Financial Guidance
Published:
2023-10-23
(Crawled : 22:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
54.47%
|
O:
-1.44%
H:
3.51%
C:
-1.75%
year
financial
results
Amneal Adds Two Denosumab Biosimilars to U.S. Pipeline, Expanding Oncology Portfolio
Published:
2023-10-12
(Crawled : 14:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
27.62%
|
O:
0.24%
H:
0.95%
C:
-9.74%
Amneal to Report Third Quarter 2023 Results on November 7, 2023
Published:
2023-10-05
(Crawled : 12:30)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
27.62%
|
O:
0.71%
H:
0.95%
C:
-7.8%
report
results
Amneal Receives U.S. FDA Approval for Calcium Gluconate Injection
Published:
2023-09-06
(Crawled : 22:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
40.31%
|
O:
3.14%
H:
0.0%
C:
-6.09%
fda
approval
injection
Amneal Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate
Published:
2023-09-06
(Crawled : 14:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
40.31%
|
O:
3.14%
H:
0.0%
C:
-6.09%
fda
approval
Amneal to Participate at the 2023 Wells Fargo Healthcare Conference
Published:
2023-08-25
(Crawled : 18:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
33.0%
|
O:
0.74%
H:
0.0%
C:
-3.69%
conference
JAMA Neurology Publishes Phase 3 Study Results Comparing IPX203 to Immediate-Release Carbidopa/Levodopa for Parkinson’s Disease
Published:
2023-08-24
(Crawled : 22:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
31.05%
|
O:
0.49%
H:
0.36%
C:
-1.95%
ipx203
disease
parkinson’s
results
study
Generic Drugs Market is Projected To Reach USD 835.7 Billion By 2032, Growing at A CAGR of 8.1% | Valuates Reports
Published:
2023-08-09
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
$20.2
510
|
Health Technology
|
17.85%
|
O:
1.92%
H:
0.0%
C:
0.0%
TEVA
|
$12.905
0.98%
5.9M
|
Health Technology
|
34.76%
|
O:
0.1%
H:
1.33%
C:
-1.12%
GSK
|
$39.585
0.8%
1.1M
|
Health Technology
|
13.21%
|
O:
0.14%
H:
0.8%
C:
0.43%
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
19.64%
|
O:
0.0%
H:
0.67%
C:
-5.58%
reach
growing
market
Amneal Reports Second Quarter 2023 Financial Results
Published:
2023-08-04
(Crawled : 11:00)
- biospace.com/
AMRX
|
$5.4
0.75%
300K
|
Health Technology
|
63.91%
|
O:
10.09%
H:
18.61%
C:
14.17%
financial
results
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
71%
29%
Top 10 Gainers
AGBA
|
News
|
$1.27
217.5%
120M
|
Finance
EGOX
|
$0.0503
39.72%
320M
|
RWOD
|
$10.52
31.56%
5.9M
|
n/a
ZCMD
|
$1.905
31.38%
30M
|
Commercial Services
MRDB
4
|
$0.536
27.65%
2M
|
n/a
BSFC
|
$0.0822
27.64%
75M
|
Manufacturing
TPET
|
$0.4121
25.68%
45M
|
n/a
NVFY
|
$2.65
25.59%
33M
|
Consumer Durables
INDO
|
$5.1
25.0%
15M
|
Energy Minerals
CHRO
|
$1.53
24.9%
100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.